文献速递衰弱、肌少症与跌倒老年综合评估

端粒长度与衰弱:赫尔辛基出生队列研究

Telomere Length and Frailty: The Helsinki Birth Cohort Study.
PubMed 文献 · J Am Med Dir Assoc · 2018-06-28

该纵向队列研究纳入1078名67至79岁芬兰赫尔辛基出生队列老年人,在平均61岁和71岁测量相对白细胞端粒长度(LTL),71岁时按Fried标准评估衰弱。横断面分析显示较短相对LTL与衰弱相关,但10年随访中端粒缩短与衰弱无关,提示短LTL可能是衰弱的生物标志物。

要点

  • 61岁时相对LTL每增加1单位,校正混杂后衰弱相对风险比为0.28(95%CI 0.08-0.97)。
  • 71岁时相对LTL与衰弱相关(RRR 0.18,95%CI 0.04-0.81),进一步校正后关联减弱。
  • 10年随访中未观察到端粒缩短与衰弱之间的关联。

核心结论

  • 较短相对LTL在横断面和纵向分析中与衰弱相关,但端粒缩短与衰弱无关,提示短LTL可能是衰弱的生物标志物。

研究设计与样本

  • 纵向队列研究,纳入赫尔辛基出生队列研究中1078名67至79岁老年人,出生于1934至1944年间。
  • 在平均61岁和71岁采用定量实时聚合酶链反应测量相对白细胞端粒长度,71岁时按Fried标准评估衰弱。

主要发现

  • 队列平均相对LTL在平均61岁时为1.40±0.29,在平均71岁时为0.86±0.30。
  • 61岁时相对LTL与衰弱显著相关:每1单位增加,衰弱相对风险比为0.28(95%CI 0.08-0.97),校正多个混杂因素。
  • 71岁时相对LTL与衰弱相关(RRR 0.18,95%CI 0.04-0.81),校正性别、年龄和成年社会经济地位后,进一步校正 attenuate 该关联。
  • 10年随访期间未观察到端粒缩短与衰弱之间的关联。

临床怎么用

  • 短相对LTL可能作为识别衰弱老年人的生物标志物,但端粒缩短动态不推荐用于预测衰弱发生。

局限性

  • 71岁时相对LTL与衰弱的关联在进一步校正后减弱,提示结果受混杂因素影响。
  • 10年随访中未发现端粒缩短与衰弱关联,横断面关联不能推断因果关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Telomere length is associated with aging-related pathologies. Although the association between telomere length and frailty has been studied previously, only a few studies assessing longitudinal changes in telomere length and frailty exist. DESIGN: Longitudinal cohort study. SETTING AND PARTICIPANTS: A subpopulation of the Helsinki Birth Cohort Study consisting of 1078 older adults aged 67 to 79 years born in Helsinki, Finland, between 1934 and 1944. MEASURES: Relative leukocyte telomere length (LTL) was measured using quantitative real-time polymerase chain reaction at the average ages of 61 and 71 years, and at the latter the participants were assessed for frailty according to Fried criteria. RESULTS: The mean ± SD relative LTLs were 1.40 ± 0.29 (average age 61 years) and 0.86 ± 0.30 (average age 71 years) for the cohort. A trend of shorter mean relative LTL across frailty groups was observed at 61 years (P = .016) and at 71 years (P = .057). Relative LTL at age 61 years was significantly associated with frailty: per 1-unit increase in relative LTL, the corresponding relative risk ratio (RRR) of frailty was 0.28 (95% confidence interval [CI] 0.08-0.97), adjusting for several confounders. Also, LTL at age 71 years was associated with frailty (RRR 0.18, 95% CI 0.04-0.81) after adjustment for sex, age, and adult socioeconomic status, but further adjustment attenuated the association. No associations between telomere shortening and frailty were observed during the 10-year follow-up. CONCLUSIONS: Shorter relative LTL was associated with frailty in cross-sectional and longitudinal analyses, but telomere shortening was not, suggesting that short LTL may be a biomarker of frailty.

来源:J Am Med Dir Assoc,查看原文。版权归原作者所有。

引用

  1. Haapanen MJ, Perälä MM, Salonen MK, et al. Telomere Length and Frailty: The Helsinki Birth Cohort Study. J Am Med Dir Assoc. 2018. PMID: 30056950. doi:10.1016/j.jamda.2018.05.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。